Patient No. | Phenotype | THC response | |||
---|---|---|---|---|---|
Entitiy | lineage dependency is marked (+) aberrantly expressed antigens are separately indicated | % viable cells at 50 μM | IC50 (μM) | ||
T-lymphatic | B-lymphatic | myeloid | |||
K562 | − | − | + | 87 | 62 |
M07e | − | − | + | 81 | 59 |
HL60 | CD4 | − | + | 15 | 38 |
Kasumi1 | CD4 | − | + | 14 | 35 |
MV4-11 | CD4 | − | + | 3 | 39 |
MOLM14 | CD4 | − | + | 18 | 44 |
MOLM13 | CD4 | − | + | 3 | 33 |
Jurkat | + | − | − | 31 | 46 |